Anna C. Salzberg
Nature Biotechnology · 2007
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from Anna C. Salzberg's perspective
Ordered by how strongly the researchers Anna C. Salzberg trusts endorse each paper. Same corpus, a different order for every researcher.
- Implications of protein flexibility for drug discovery
- The druggable genome (Nature reviews. Drug discovery)
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
- Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update (Fundamental & Clinical Pharmacology)
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 (Science)
- Structural Mechanism for Statin Inhibition of HMG-CoA Reductase (Science)
- A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. (Journal of Medicinal Chemistry)
- Enzyme Dynamics During Catalysis (Science)
- Predicting druggable binding sites at the protein-protein interface.
Their papers
- Structure-based maximal affinity model predicts small-molecule druggability (2007) — 643 citations